Krsnaa Diagnostics Gets In-Principle Approval for Warrant Issue

Krsnaa Diagnostics Ltd has received in-principle approval from BSE Limited and National Stock Exchange of India Limited for the preferential issuance of 16,21,000 warrants. These warrants are convertible into an equal number of equity shares of face value Rs. 5/- each, at an issue price of Rs. 566/- per share. The issuance is planned on a preferential basis to the Promoter and Promoter Group. The company is awaiting a corrected approval letter from BSE due to factual errors in the initial one. This move is a significant corporate action aimed at strengthening the promoter's stake and potentially raising capital.